Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

33.78
+1.926.03%
Post-market: 33.73-0.0550-0.16%19:59 EDT
Volume:14.71M
Turnover:492.64M
Market Cap:7.88B
PE:-54.22
High:34.46
Open:31.67
Low:31.60
Close:31.86
52wk High:65.30
52wk Low:13.74
Shares:233.31M
Float Shares:212.45M
Volume Ratio:1.11
T/O Rate:6.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:24.32
PE(LYR):65.94

Loading ...

Hims & Hers price target raised to $39 from $29 at Barclays

TIPRANKS
·
Jun 18

Hims & Hers Stands to Get a Big Chunk of the $2.2B Peptides Market -- Barrons.com

Dow Jones
·
Jun 17

Movement Alert|Hims & Hers Health Rises 5.45% in Regular Trading, Goldman Sachs GLP-1 Market Upgrade and Sales Improvement Signals Fuel Rally

Market Focus
·
Jun 16

BUZZ-U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood, Mobileye

Reuters
·
Jun 16

BUZZ-Leerink sees about $440 million peptide revenue chance for Hims & Hers

Reuters
·
Jun 16

Hims & Hers files initial beneficial ownership statement for new director Kofi Owusu Amoo-Gottfried

Reuters
·
Jun 16

Hims & Hers Health holds annual shareholder meeting, directors elected

Reuters
·
Jun 16

Moderately bullish activity in Hims and Hers Health with shares up 10.7%

TIPRANKS
·
Jun 16

Movement Alert|Hims & Hers Health Rises 5.72% in Regular Trading, Goldman Sachs GLP-1 Market Upgrade and Improving Sales Data Fuel Rally

Market Focus
·
Jun 15

What Hims & Hers Health (HIMS)'s Eucalyptus Deal and Longevity Push Means For Shareholders

Simply Wall St.
·
Jun 13

Movement Alert|Hims & Hers Health Falls 5.73% in Regular Trading, GLP-1 Transition Costs and Analyst Downgrade Weigh on Shares

Market Focus
·
Jun 12

Moderately bullish activity in Hims and Hers Health with shares up 1.47%

TIPRANKS
·
Jun 10

Movement Alert|Hims & Hers Health Rises 5.06% in Regular Trading, Eucalyptus Acquisition Integration Continues to Fuel Optimism

Market Focus
·
Jun 09

Skip the Oura Ring IPO. Buy These 10 Stocks Instead.

InvestorPlace
·
Jun 07

Movement Alert|Hims & Hers Health Falls 6% in Regular Trading, GLP-1 Transition Costs and FDA Regulatory Risks Weigh on Shares

Market Focus
·
Jun 05

Cboe data shows mixed options sentiment in Hims and Hers Health with shares up 5.0%

TIPRANKS
·
Jun 05

Movement Alert|Hims & Hers Health Rises 5.93% in Regular Trading, Eucalyptus Acquisition Completion Bolsters Global Platform Expansion

Market Focus
·
Jun 04

Hims & Hers names Dr. Anant Vinjamoori chief medical officer of Hims brand

Reuters
·
Jun 04

Hims & Hers Names DR. Anant Vinjamoori as Chief Medical Officer of Hims

THOMSON REUTERS
·
Jun 04

BUZZ-U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway

Reuters
·
Jun 03